Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Highbridge Reports Zero Stake in Futurewave Acquisition

Highbridge Capital Management, LLC filed an amended beneficial ownership statement with the SEC on November 16, 2026, disclosing that it holds zero ordinary shares of Futurewave Acquisition Corporation as of September 30, 2026.

Nitish Kishor | 16 November 2026

RTW Investments Reports 5.5% Stake in Solid Biosciences

RTW Investments, LP and its Managing Partner Roderick Wong filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 5,905,426 shares of Solid Biosciences Inc. common stock as of September 30, 2026.

Shwetambri Chauhan | 16 November 2026

Highbridge Reports 5.1% Stake in Harvard Ave Acquisition

Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 814,229 Class A Ordinary Shares of Harvard Ave Acquisition Corporation as of September 30, 2026.

Aakashdeep | 16 November 2026

Highbridge Reports 6.1% Stake in LaFayette Acquisition

Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of ordinary shares of LaFayette Acquisition Corp. as of September 30, 2026.

Nitish Kishor | 16 November 2026

Highbridge Reports Zero Stake in Peace Acquisition Corp.

Highbridge Capital Management, LLC filed an amended beneficial ownership statement with the SEC on November 16, 2026, disclosing that it holds zero ordinary shares of Peace Acquisition Corp. as of September 30, 2026.

Nitish Kishor | 16 November 2026

Highbridge Reports 4.98% Warrant-Based Stake in INmune Bio

Highbridge Capital Management, LLC filed Amendment No. 2 to a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 1,454,400 shares of INmune Bio, Inc. common stock issuable upon exercise of warrants held by Highbridge-managed funds.

Shwetambri Chauhan | 16 November 2026

Highbridge Reports 4.8% Stake in Sharplink via Warrants

Highbridge Capital Management, LLC filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 11,010,766 shares of Sharplink, Inc. common stock as of September 30, 2026.

Vinay Lochav | 16 November 2026

Highbridge Capital Discloses 5.5% Stake in Lake Superior Acquisition

Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, reporting beneficial ownership of 654,922 Class A Ordinary Shares of Lake Superior Acquisition Corp as of September 30, 2026.

Manish Choudhary | 16 November 2026

RTW Investments Reports 9.9% Stake in Stoke Therapeutics

RTW Investments, LP and Roderick Wong filed Amendment No. 8 to Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 6,537,475 shares of Stoke Therapeutics, Inc. common stock as of September 30, 2026.

Anjali Anand | 16 November 2026

Highbridge Discloses 5.1% Stake in Lionheart Holdings

Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 1,105,223 Class A Ordinary Shares of Lionheart Holdings as of September 30, 2026.

Shwetambri Chauhan | 16 November 2026
Support

Hi! How can we help you today?

Loading…